tiprankstipranks
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
US Market
CAMP
CAMP4 Therapeutics Corporation
RESEARCH TOOLSreports

CAMP4 Therapeutics Corporation (CAMP) Financial Statements

Compare
123 Followers

CAMP4 Therapeutics Corporation Financial Overview

CAMP4 Therapeutics Corporation's market cap is currently $236.75M. The company's EPS TTM is $-0.86; its P/E ratio is -2.32; CAMP4 Therapeutics Corporation is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Nov 23Feb 23Feb 22
Income Statement
Total Revenue$ 3.50M$ 652.00K$ 350.00K$ 0.00$ 295.84M
Gross Profit$ 1.86M$ 652.00K$ 350.00K$ 0.00$ 121.89M
Operating Income$ -52.06M$ -53.09M$ -51.88M$ -45.00M$ -15.31M
EBITDA$ -50.42M$ -51.39M$ -50.20M$ -44.12M$ 7.49M
Net Income$ -80.40M$ -51.79M$ -49.29M$ -44.19M$ -31.15M
Balance Sheet
Cash & Short-Term Investments$ 109.52M$ 64.04M$ 38.38M$ 83.19M$ 91.11M
Total Assets$ 117.81M$ 78.31M$ 54.95M$ 102.55M$ 402.29M
Total Debt$ 1.97M$ 8.65M$ 11.69M$ 12.39M$ 209.17M
Net Debt$ -107.54M$ -55.39M$ -26.69M$ -70.80M$ 118.05M
Total Liabilities$ 70.10M$ 15.16M$ 178.68M$ 180.08M$ 322.11M
Stockholders' Equity$ 47.70M$ 63.14M$ -123.73M$ -77.53M$ 80.18M
Cash Flow
Free Cash Flow$ -29.83M$ -46.00M$ -44.83M$ -42.57M$ -17.52M
Operating Cash Flow$ -29.55M$ -45.56M$ -44.16M$ -38.54M$ -4.22M
Investing Cash Flow$ -243.00K$ -441.00K$ -678.00K$ -4.03M$ -7.58M
Financing Cash Flow$ 75.89M$ 71.66M$ 301.00K$ 100.16M$ -2.64M
Currency in USD

CAMP4 Therapeutics Corporation Earnings and Revenue History

Income Statement >

CAMP4 Therapeutics Corporation Debt to Assets

Balance Sheet >

CAMP4 Therapeutics Corporation Cash Flow

Cash Flow >

CAMP4 Therapeutics Corporation Forecast EPS vs Actual EPS

Earnings >